Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated filings document the formal disclosures of a large health care company organized around UnitedHealthcare and Optum. Proxy materials describe board governance, executive compensation, shareholder voting matters and the company’s complementary businesses: UnitedHealthcare health coverage and Optum clinical, data, product, pharmacy and care services.
Current reports on Form 8-K cover operating and financial results, Regulation FD communications, strategy and market-position discussions, director appointments, compensation arrangements and other material-event disclosures. The filing record also documents governance practices, capital-structure and compensation matters, risk-related business context and the regulatory reporting framework for a Delaware public operating company in the health care sector.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director and CEO Stephen J. Hemsley received an award of 61 shares of common stock on March 17, 2026. This was reported as a grant or award of dividend equivalents on vested deferred stock units at a stated price of $0.0000 per share, and the dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
After this transaction, Hemsley directly holds 362,628.942 shares of common stock. He also has indirect holdings of 355.091 shares through a 401(k) plan and 692,255 shares held by trusts, which include 10,380 shares previously held directly and contributed to the trusts on January 29, 2026 in a transaction noted as exempt from reporting pursuant to Rule 16a-13.
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award. On March 17, 2026, he acquired 14 shares of Common Stock at a price of $0.00 per share as a grant/award acquisition.
According to the footnote, these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. After this transaction, Baker directly holds 1,820 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this award, McSweeney directly holds a reported total of 15,552.923 UnitedHealth Group common shares.
UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units, meaning they function as routine, compensation-related accruals rather than an open-market purchase. After this acquisition, Hooper directly holds a total of 41,586 shares of UnitedHealth Group common stock, indicating this is a small, incremental increase to an existing position.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small stock award. On March 17, 2026, Gil acquired 8 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units and subject to the same terms as those units. After this award, Gil holds 2,083 shares directly and 3,800 shares indirectly through a trust, indicating this is a routine, compensation-related update rather than an open-market trade.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small compensation-related equity acquisition. He received 1 share-equivalent of common stock on 2026-03-17 as dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this award, he directly owns 126 shares of common stock.
Conway Patrick Hugh reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC reported that Patrick Hugh Conway, Chief Executive Officer of Optum, received a grant of 125.021 shares of common stock on March 17, 2026 at a price of $0.00 per share. These shares represent dividend equivalents on his outstanding restricted stock units and will vest or be forfeited under the same conditions as those units. Following this award, his directly held common stock position increased to 18,604.991 shares, indicating a routine, compensation-related adjustment rather than an open-market purchase.
UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz filed an initial ownership report showing direct holdings of common stock and several grants of non-qualified stock options. He holds 10,137.881 shares of common stock and multiple option awards with exercise prices between $252.37 and $521.97 expiring from 2030 through 2036, many vesting in annual installments.
UnitedHealth Group Incorporated announced that senior leaders will participate in a question-and-answer interview at the Barclays 28th Annual Global Healthcare Conference. They plan to discuss the company’s strategy, market positions, recent results and expectations for its end markets. A live audio webcast will be available through the investor relations section of the company’s website.
UnitedHealth Group Incorporated filed a Form S-3 shelf registration dated March 2, 2026 to register a range of securities, including debt securities, preferred stock, common stock, warrants and guarantees for offerings from time to time after the effective date. The prospectus explains offering mechanics and distribution methods. As context, 907,675,839 shares of common stock were outstanding as of February 20, 2026.